Medical Tests
Explore lab tests, blood work, and imaging exams with plain-language preparation and overview pages.
Browse Directory Sections
Tests starting with A (6,266)
Other
AH-8533 [Mass/volume] in Urine by Confirmatory method
Blood test
AHCY gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
AHCY gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Blood test
AIP gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
AIP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Blood test
AIRE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Other
AJCC cancer staging manual [PhenX]
Other
AKB48 N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Blood test
AKT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
AKT1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALAS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALDH3A2 gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
ALDOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALDOB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALK gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALK gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
Blood test
ALK gene rearrangements [Presence] in Blood or Tissue by FISH
Blood test
ALOX3+ALOX12B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALPL gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
ALPL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Other
ALPRAZolam [Mass/mass] in Hair
Other
ALPRAZolam [Mass/mass] in Meconium
Other
ALPRAZolam [Mass/mass] in Meconium by Confirmatory method
Other
ALPRAZolam [Mass/mass] in Stool by Confirmatory method
Other
ALPRAZolam [Mass/mass] in Tissue
Other
ALPRAZolam [Mass/mass] in Tissue by Confirmatory method
Blood test
ALPRAZolam [Mass/volume] in Blood
Blood test
ALPRAZolam [Mass/volume] in Blood by Confirmatory method
Other
ALPRAZolam [Mass/volume] in Body fluid
Other
ALPRAZolam [Mass/volume] in Body fluid by Confirmatory method
Other
ALPRAZolam [Mass/volume] in Gastric fluid
Other
ALPRAZolam [Mass/volume] in Saliva (oral fluid)
Other
ALPRAZolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Blood test
ALPRAZolam [Mass/volume] in Serum or Plasma
Blood test
ALPRAZolam [Mass/volume] in Serum or Plasma --trough
Blood test
ALPRAZolam [Mass/volume] in Serum or Plasma by Confirmatory method
Other
ALPRAZolam [Mass/volume] in Specimen
Other
ALPRAZolam [Mass/volume] in Stool
Other
ALPRAZolam [Mass/volume] in Urine
Other
ALPRAZolam [Mass/volume] in Urine by Confirmatory method
Other
ALPRAZolam [Mass/volume] in Vitreous fluid
Other
ALPRAZolam [Mass] of Dose
Other
ALPRAZolam [Measurement] in Saliva (oral fluid)
Blood test
ALPRAZolam [Measurement] in Serum or Plasma
Other
ALPRAZolam [Measurement] in Urine
Blood test
ALPRAZolam [Moles/volume] in Serum or Plasma
Other
ALPRAZolam [Moles/volume] in Specimen
Other
ALPRAZolam [Presence] in Cord tissue by Confirmatory method
Other
ALPRAZolam [Presence] in Cord tissue by Screen method
Other
ALPRAZolam [Presence] in Gastric fluid
Other
ALPRAZolam [Presence] in Saliva (oral fluid)
Blood test
ALPRAZolam [Presence] in Serum or Plasma
Other
ALPRAZolam [Presence] in Specimen
Other
ALPRAZolam [Presence] in Urine
Other
ALPRAZolam [Presence] in Urine by Confirmatory method
Other
ALPRAZolam [Presence] in Urine by Screen method
Other
ALPRAZolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Other
ALPRAZolam cutoff [Mass/volume] in Urine for Confirmatory method
Blood test
ALPRAZolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Blood test
ALPRAZolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Other
ALPRAZolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
Blood test
ALS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALS4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
AM-2201 (synthetic cannabinoid) [Presence] in Blood
Other
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
Blood test
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
Other
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Other
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
Other
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
Other
AM694 N-5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Blood test
AML/MDS gene 7q31 deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
AML/MDS gene CEP 8 trisomy [Presence] in Blood or Tissue by Molecular genetics method
Blood test
AMPAR1 Ab [Measurement] in Serum
Other
AMPAR1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Blood test
AMPAR1 Ab [Presence] in Serum by Cell binding immunofluorescent assay
Blood test
AMPAR1 Ab [Presence] in Serum by Immunofluorescence
Other
AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Blood test
AMPAR1 Ab [Titer] in Serum by Cell binding immunofluorescent assay
Other
AMPAR1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Blood test
AMPAR1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Other
AMPAR1+AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Blood test
AMPAR1+AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Blood test
AMPAR1+AMPAR2 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay
Blood test
AMPAR2 Ab [Measurement] in Serum
Other
AMPAR2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Blood test
AMPAR2 Ab [Presence] in Serum by Cell binding immunofluorescent assay
Blood test
AMPAR2 Ab [Presence] in Serum by Immunofluorescence
Other
AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Blood test
AMPAR2 Ab [Titer] in Serum by Cell binding immunofluorescent assay
Other
AMPAR2 IgG Ab [Measurement] in Cerebral spinal fluid
Blood test
AMPAR2 IgG Ab [Measurement] in Serum or Plasma
Other
AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Other
AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Blood test
AMPAR2 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay
Blood test
AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Other
AMPAR2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Blood test
AMPAR2 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
Blood test
AMPD1 gene p.Gln12Ter and p.Pro48Leu [Presence] in Blood or Tissue by Molecular genetics method
Blood test
ANG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal